• Science & Technology
• Health & Medicine

Scientists develop new precision medicine approach for pancreatic cancer

Scientists from the University of Glasgow are developing new ways to predict who will respond to drugs targeting damaged DNA in pancreatic cancer.  Scientists from the University of Glasgow are developing new ways to predict who will respond to drugs targeting damaged DNA in pancreatic cancer. 

12 October 2020

• Science & Technology
• Health & Medicine

Vital rethinking in cancer early detection needed to save lives

The Cancer Research UK Roadmap sets out a plan to overcome the challenges hampering early detection of cancer. The Cancer Research UK Roadmap sets out a plan to overcome the challenges hampering early detection of cancer.

6 October 2020

• Health & Medicine

New drug targeting high-risk children’s cancer is ready for trials

A new drug that has passed safety tests in adults is likely to be effective against the aggressive childhood cancer neuroblastoma. A new drug that has passed safety tests in adults is likely to be effective against the aggressive childhood cancer neuroblastoma.

5 October 2020

• Health & Medicine

HPV vaccine reduces cervical cancer risk

Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.   Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.  

1 October 2020

• Personal Stories

More diversity is needed in patient information and campaigns

We spoke to Siobhan, Nikki and Jessica about their experiences of childhood cancer. We spoke to Siobhan, Nikki and Jessica about their experiences of childhood cancer.

18 September 2020

• Health & Medicine

Lung cancer risks becoming ‘forgotten disease’ of the coronavirus pandemic  

At least 14,000 fewer people have been urgently referred for lung cancer tests since March.  At least 14,000 fewer people have been urgently referred for lung cancer tests since March. 

17 September 2020

• Health & Medicine

Targeted drug for lung cancer approved for NHS use in England

The National Institute for Health and Care Excellence has approved the drug osimertinib to treat some adults in England with untreated, advanced lung cancer. The National Institute for Health and Care Excellence has approved the drug osimertinib to treat some adults in England with untreated, advanced lung cancer.

11 September 2020

• Health & Medicine

Myeloma maintenance treatment not recommended on NHS in England

Cancer drug lenalidomide receives an initial rejection to treat some adults with myeloma following a stem cell transplant. Cancer drug lenalidomide receives an initial rejection to treat some adults with myeloma following a stem cell transplant.

10 September 2020

• Health & Medicine

Rare bowel cancer treatment combo gets initial no for NHS use in England  

A drug combination for people with a rare type of bowel cancer has received an initial rejection from the National Institute for Health and Care Excellence. A drug combination for people with a rare type of bowel cancer has received an initial rejection from the National Institute for Health and Care Excellence.

4 September 2020

• Science & Technology

Children and young people with cancer who have relapsed can get rapid access to new treatments, thanks to new Cancer Research UK trial

Children and young people in the UK with cancers that have come back can now access new personalised treatments quicker than ever before. Children and young people in the UK with cancers that have come back can now access new personalised treatments quicker than ever before.

4 September 2020

• Science & Technology

Cancer Research UK and AstraZeneca’s new antibody maturation technique yields high-affinity Arginase 2 antibody

Researchers in Cambridge have pioneered the development of an innovative affinity maturation technique to generate high-affinity antibody against Arginase 2. Researchers in Cambridge have pioneered the development of an innovative affinity maturation technique to generate high-affinity antibody against Arginase 2.

3 September 2020